TherapeuticsMD
TXMD
$2.22
Share price
4.23%
Change (1 day)
-46.51%
Change (1 year)
Categories
TherapeuticsMD (TXMD) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $13.42 M
According to TherapeuticsMD's latest financial reports the company's total liabilities are $13.42 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
TherapeuticsMD - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $55.31 M | -78.98% |
| 2021-12-31 | $0.26 B | -13.91% |
| 2020-12-31 | $0.30 B | 19.01% |
| 2019-12-31 | $0.25 B | 124.34% |
| 2018-12-31 | $0.11 B | 759.23% |
| 2017-12-31 | $13.32 M | -11.09% |
| 2016-12-31 | $14.98 M | 40.47% |
| 2015-12-31 | $10.66 M | -0.23% |
| 2014-12-31 | $10.69 M | 46.08% |
| 2013-12-31 | $7.31 M | -0.56% |
| 2012-12-31 | $7.35 M | 133.58% |
| 2011-12-31 | $3.15 M | 1253.1% |
| 2010-12-31 | $0.23 M | -79.94% |
| 2009-12-31 | $1.16 M | 3149.59% |
| 2008-12-31 | $0.03 M | -54.1% |
| 2007-12-31 | $0.07 M | -56.72% |
| 2006-12-31 | $0.17 M | -63.54% |
| 2005-12-31 | $0.49 M | 1228.79% |
| 2004-12-31 | $0.03 M | 15.59% |
| 2003-12-31 | $0.03 M | 91.08% |
| 2002-12-31 | $0.01 M | -27.06% |
| 2001-12-31 | $0.02 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $128.53 B | 957,416.39% | 🇺🇸 USA |
 AbbVie ABBV | $140.82 B | 1,048,968.83% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $22.93 M | 70.84% | 🇺🇸 USA |
 Royalty Pharma RPRX | $6.26 B | 46,586.31% | 🇬🇧 UK |
 Lannett Company LCI | $0.74 B | 5,463.79% | 🇺🇸 USA |